Magnolia Capital Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Magnolia Capital Advisors's PFE Position: Q1 2026 in Review
Magnolia Capital Advisors increased its Pfizer (PFE) stake by 22% in Q1 2026, buying an estimated $75.8K and bringing the position to 15,560 shares worth $437K. The position accounts for 0.09% of the portfolio, ranked #214.
Magnolia Capital Advisors first reported a position in PFE in Q4 2019 and has held it in 21 quarters since. The position peaked at $863K in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Magnolia Capital Advisors held 15,560 shares of Pfizer worth $437K as of Q1 2026.
- Magnolia Capital Advisors bought 2,848 Pfizer shares in Q1 2026, an estimated $75.8K.
- Pfizer made up 0.09% of Magnolia Capital Advisors's portfolio in Q1 2026, its #214 holding.
- Magnolia Capital Advisors first reported a position in Pfizer in Q4 2019 and has held it in 21 quarters since.
- Magnolia Capital Advisors's Pfizer position peaked at $863K in Q4 2021.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Magnolia Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.